ADC Therapeutics Raises $86.6 Million in Financing, Amends Loan and Royalty Deals
ADC Therapeutics announced a $86.6 million private placement of common shares and pre-funded warrants, alongside amendments to its Blue Owl loan and HCR royalty agreements. The loan amendment follows a $70 million prepayment.